JP2005501108A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005501108A5 JP2005501108A5 JP2003522525A JP2003522525A JP2005501108A5 JP 2005501108 A5 JP2005501108 A5 JP 2005501108A5 JP 2003522525 A JP2003522525 A JP 2003522525A JP 2003522525 A JP2003522525 A JP 2003522525A JP 2005501108 A5 JP2005501108 A5 JP 2005501108A5
- Authority
- JP
- Japan
- Prior art keywords
- stroke
- post
- composition according
- treatment
- neurodegeneration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000006011 Stroke Diseases 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 4
- 230000004770 neurodegeneration Effects 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- NGHTXZCKLWZPGK-UHFFFAOYSA-N nefiracetam Chemical compound CC1=CC=CC(C)=C1NC(=O)CN1C(=O)CCC1 NGHTXZCKLWZPGK-UHFFFAOYSA-N 0.000 claims 3
- 229950004663 nefiracetam Drugs 0.000 claims 3
- 238000011084 recovery Methods 0.000 claims 2
- 208000027534 Emotional disease Diseases 0.000 claims 1
- 206010037180 Psychiatric symptoms Diseases 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 230000002269 spontaneous effect Effects 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2001/007180 WO2003018005A1 (en) | 2001-08-22 | 2001-08-22 | use of nefiracetam for treating neurodegeneration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005501108A JP2005501108A (ja) | 2005-01-13 |
| JP2005501108A5 true JP2005501108A5 (https=) | 2008-10-16 |
Family
ID=11737657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003522525A Pending JP2005501108A (ja) | 2001-08-22 | 2001-08-22 | 神経変性治療におけるネフィラセタムの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20040192759A1 (https=) |
| EP (1) | EP1420782B1 (https=) |
| JP (1) | JP2005501108A (https=) |
| AT (1) | ATE404192T1 (https=) |
| CA (1) | CA2457982C (https=) |
| DE (1) | DE60135390D1 (https=) |
| ES (1) | ES2311537T3 (https=) |
| WO (1) | WO2003018005A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060241144A1 (en) * | 2005-04-20 | 2006-10-26 | Albert Cha | Method for treating apathy syndrome |
| RU2329804C2 (ru) * | 2006-03-28 | 2008-07-27 | Валентина Ивановна Ахапкина | Вещество, обладающее нейротропной - нейромодуляторной активностью |
| DK3260118T3 (da) * | 2008-10-16 | 2021-04-19 | Univ Johns Hopkins | Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion |
| NO2490685T3 (https=) * | 2009-10-22 | 2018-05-12 | ||
| EA202092673A3 (ru) * | 2010-02-09 | 2021-05-31 | Дзе Джонс Хопкинс Юниверсити | Способы и композиции для улучшения когнитивной функции |
| US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
| WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| AU2014228512A1 (en) | 2013-03-15 | 2015-10-01 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
| CA2986598C (en) | 2015-05-22 | 2023-09-26 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4749700A (en) * | 1984-10-23 | 1988-06-07 | Nastech Pharmaceutical Co, Inc. | Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same |
| CA2067614C (en) * | 1991-05-02 | 2002-07-30 | Eiichi Otomo | Agent for improving dementia |
| JP3388778B2 (ja) * | 1991-05-02 | 2003-03-24 | 第一製薬株式会社 | 脳血管性痴呆改善剤 |
| EP1020189B1 (en) * | 1997-07-15 | 2004-05-12 | Daiichi Pharmaceutical Co., Ltd. | Nefiracetam for prevention and treatment of amnesia caused by propofol |
| JPH1180027A (ja) * | 1997-09-12 | 1999-03-23 | Dai Ichi Seiyaku Co Ltd | 向知性薬 |
| US6423739B1 (en) * | 2000-02-23 | 2002-07-23 | Daiichi Pharmaceutical Co., Ltd. | Method for aiding cerebral recovery following neurodegeneration |
-
2001
- 2001-08-22 CA CA002457982A patent/CA2457982C/en not_active Expired - Fee Related
- 2001-08-22 EP EP01958395A patent/EP1420782B1/en not_active Expired - Lifetime
- 2001-08-22 JP JP2003522525A patent/JP2005501108A/ja active Pending
- 2001-08-22 AT AT01958395T patent/ATE404192T1/de not_active IP Right Cessation
- 2001-08-22 WO PCT/JP2001/007180 patent/WO2003018005A1/en not_active Ceased
- 2001-08-22 ES ES01958395T patent/ES2311537T3/es not_active Expired - Lifetime
- 2001-08-22 US US10/487,320 patent/US20040192759A1/en not_active Abandoned
- 2001-08-22 DE DE60135390T patent/DE60135390D1/de not_active Expired - Lifetime
-
2007
- 2007-09-28 US US11/863,808 patent/US20080076820A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0108977B8 (pt) | compostos azacíclicos, composição farmacêutica e uso de um composto ou sal farmaceuticamente aceitável do mesmo | |
| RU2001128504A (ru) | Композиции для стимулирования роста | |
| EP1651195A4 (en) | PHARMACEUTICAL PROCESSES, DOSIERSCHEMATA AND DOSAGE FORMS FOR THE TREATMENT OF ALZHEIMER DISEASE | |
| JP2002532432A5 (https=) | ||
| RU2004105865A (ru) | Новый способ лечения | |
| RU2004136853A (ru) | (s)-4-амино-5-хлор-2-метокси-n-[1-[1-(2-тетрагидрофурилкарбонил)-4- пиперидини лметил]-4-пиперидинил]бензамид, способ его получения, содержащая его фармацевтическая композиция и промежуточное соединение для его получения | |
| JP2005507892A5 (https=) | ||
| JP2005501108A5 (https=) | ||
| EA200800880A1 (ru) | Комбинация росиглитазона и донепезила, предназначенная для улучшения когнитивной функции | |
| JP2004537500A5 (https=) | ||
| JP2006504735A5 (ja) | 絨毛性性腺刺激ホルモンを含む慢性骨盤疼痛症候群の治療用組成物 | |
| RU2006113366A (ru) | Терапевтическое лечение | |
| JP2002537232A5 (https=) | ||
| JP2005513036A5 (https=) | ||
| JP2003503453A5 (ja) | ガバペンチンおよびプレガバリンを含む相乗作用組成物 | |
| JP2003522147A5 (https=) | ||
| JP2002537256A5 (https=) | ||
| JP2003523385A5 (https=) | ||
| RU2002129298A (ru) | Применение галантамина для лечения психоневрологического поведения, связанного с болезнью альцгеймера | |
| JP2002501021A5 (https=) | ||
| CA2368352A1 (en) | Method for treating neurodegeneration | |
| RU2002122703A (ru) | Способ лечения воспалительных и воспалительно-деструктивных заболеваний пародонта | |
| JP2004262775A5 (https=) | ||
| CA2469702A1 (en) | Darifenacin for use in the treatment of urgency induced by overactive bladder | |
| TW200505427A (en) | A solid oral dosage form of metformin and glyburide and the method of preparation thereof |